Obidiugwu Kenrik Duru, MD, MSHS, discusses the prevalence, assessment and treatment of acute and chronic low back pain. This session was originally presented at IMM 2019.
This content is supported by an independent education grant funded by Pfizer, Inc., in partnership with Lilly USA, LLC.
Disclosures
Relevant financial relationships are disclosed below each name. Those with nothing listed have nothing to disclose.
2019 Internal Medicine Scientific Program Planning Committee
- Rachel P. Brook, MD, Member
- Robert K. Cato, MD, F바카라 사리트
- Daniel D. Dressler, MD, MSc, F바카라 사리트, SFHM
- Stephanie S. Faubion, MD, NCMP, IF, F바카라 사리트
- Consultantship: Mithra Pharmaceuticals, Proctor & Gamble
- Jonathan Hogan, MD
- Gregory C. Kane, MD, M바카라 사리트
- Lillian F. Lien, MD, F바카라 사리트
- Consultantship: Sanofi, Merck, Eli Lilly and Company, Novo Nordisk
- Eileen Moser, MD, M바카라 사리트
- Stock Options/Holdings: Intuitive Surgical
- Lawrence M. Phillips, MD, F바카라 사리트
- Speakers Bureau: Astellas Pharma
- Other: Merck
- William D. Surkis, MD, F바카라 사리트
- Banu E. Symington, MD, M바카라 사리트
- Michael J. Tan, F바카라 사리트
- Speakers Bureau: Pfizer, Merck, Allergen, The Medicines Company
- Alexandra S. Villa‐Forte, MD, F바카라 사리트
- Soma Wali, MD, M바카라 사리트
- Patrick E. Young, MD, F바카라 사리트, FACG, FASGE
Faculty/Speaker
- Obidiugwu Kenrik Duru, MD, MSHS